Future investigations into MAPK-AP-1 signaling dynamics may not only refine our understanding of adrenal tumor biology but also open new avenues for targeted therapeutic strategies to mitigate hormone excess. The gene discussed is FOS; the disease is adrenal gland neoplasm.